253 related articles for article (PubMed ID: 56939)
21. Low molecular weight IgM in rheumatoid arthritis and other rheumatic diseases.
Roberts-Thomson PJ; Wernick RM; Ziff M
Arthritis Rheum; 1981 Jun; 24(6):795-802. PubMed ID: 6972766
[TBL] [Abstract][Full Text] [Related]
22. Antibody-mediated leucocyte cytotoxicity to Chang human liver cells in rheumatoid arthritis and other diseases.
Panayi GS
Ann Rheum Dis; 1976 Feb; 35(1):27-31. PubMed ID: 1275578
[TBL] [Abstract][Full Text] [Related]
23. Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies.
Winchester RJ; Winfield JB; Siegal F; Wernet P; Bentwich Z; Kunkel HG
J Clin Invest; 1974 Nov; 54(5):1082-92. PubMed ID: 4138924
[TBL] [Abstract][Full Text] [Related]
24. Rheumatoid factor and antinuclear antibody in systemic lupus erythematosus, rheumatoid arthritis and infectious mononucleosis.
Ichida CK; Yokoyama M
Hawaii Med J; 1971; 30(3):170-3. PubMed ID: 4105320
[No Abstract] [Full Text] [Related]
25. A possible role of Fas-ligand-mediated "reverse signaling" in pathogenesis of rheumatoid arthritis and systemic lupus erythematosus.
Telegina E; Reshetnyak T; Moshnikova A; Proussakova O; Zhukova A; Kuznetsova A; Ivanov A; Paltsev M; Beletsky I
Immunol Lett; 2009 Jan; 122(1):12-7. PubMed ID: 19010354
[TBL] [Abstract][Full Text] [Related]
26. Expression of TLiSA1 on T cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
Tabata H; Hara M; Kitani A; Hirose T; Norioka K; Harigai M; Suzuki K; Kawakami M; Kawagoe M; Nakamura H
Clin Immunol Immunopathol; 1989 Sep; 52(3):366-75. PubMed ID: 2788052
[TBL] [Abstract][Full Text] [Related]
27. Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor.
Luthra HS; McDuffie FC; Hunder GG; Samayoa EA
J Clin Invest; 1975 Aug; 56(2):458-66. PubMed ID: 125289
[TBL] [Abstract][Full Text] [Related]
28. Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.
Zubler RH; Nydegger U; Perrin LH; Fehr K; McCormick J; Lambert PH; Miescher PA
J Clin Invest; 1976 May; 57(5):1308-19. PubMed ID: 944196
[TBL] [Abstract][Full Text] [Related]
29. The influence of fibronectin on cryoprecipitate formation in rheumatoid arthritis and systemic lupus erythematosus.
Beaulieu AD; Valet JP; Strevey J
Arthritis Rheum; 1981 Nov; 24(11):1383-8. PubMed ID: 7317115
[TBL] [Abstract][Full Text] [Related]
30. Studies on immune complexes in rheumatoid arthritis.
Bozsóky S; Merétey K; Falus A
Ann Immunol Hung; 1979; 19():117-35. PubMed ID: 399579
[No Abstract] [Full Text] [Related]
31. [Immune complex and rheumatoid arthritis].
Kasukawa R
Ryumachi; 1994 Apr; 34(2):175-6. PubMed ID: 8202835
[No Abstract] [Full Text] [Related]
32. Detection of low molecular weight IgM by immunoblot analysis in rheumatoid arthritis.
Ezaki I; Shingu M; Nobunaga M; Otsuka E
J Rheumatol; 1987 Aug; 14(4):674-9. PubMed ID: 3668973
[TBL] [Abstract][Full Text] [Related]
33. Rheumatoid factor in serum and synovial fluid.
MacSween RN; Dalakos TK; Jasani MK; Buchanan WW
Scand J Rheumatol; 1972; 1(4):177-80. PubMed ID: 4663999
[No Abstract] [Full Text] [Related]
34. Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Partial characterization and relationship to lowered complement levels.
Winchester RJ; Agnello V; Kunkel HG
Clin Exp Immunol; 1970 May; 6(5):689-706. PubMed ID: 4097828
[TBL] [Abstract][Full Text] [Related]
35. Antibody-dependent direct cytotoxicity of human lymphocytes. II. Studies on peripheral blood lymphocytes, synovial fluid cells and sera from patients with rheumatoid arthritis.
Scheinberg MA; Cathcart ES
Clin Exp Immunol; 1976 May; 24(2):323-7. PubMed ID: 1084244
[TBL] [Abstract][Full Text] [Related]
36. [Clinical application of Fc-rosette. III. Reduction of Fc receptor bearing cells in the peripheral blood of SLE and rheumatoid synovial fluids (author's transl)].
Nakai H; Morito T; Tanimoto K; Horiuchi Y
Ryumachi; 1977 Jul; 17(4):373-80. PubMed ID: 905902
[No Abstract] [Full Text] [Related]
37. [Serum and articular immune complexes detection by the antibody-dependent cytotoxicity inhibition reaction in inflammatory rheumatological conditions and connective tissue disorders (author's transl)].
Meyer O; Descamps B; Ryckewaert A; Peltier A
Nouv Presse Med; 1979 Mar; 8(14):1165-9. PubMed ID: 313556
[TBL] [Abstract][Full Text] [Related]
38. Anti-Fc gamma receptor III autoantibody is associated with soluble receptor in rheumatoid arthritis serum and synovial fluid.
Lamour A; Baron D; Soubrane C; Cartron J; Khayat D; Adler Y; Le Goff P; Youinou P
J Autoimmun; 1995 Apr; 8(2):249-65. PubMed ID: 7612151
[TBL] [Abstract][Full Text] [Related]
39. Immunoglobulin and receptors for C3 on lymphocytes from patients with rheumatoid arthritis.
Mellbye OJ; Messner RP; DeBord JR; Williams RC
Arthritis Rheum; 1972; 15(4):371-80. PubMed ID: 4114708
[No Abstract] [Full Text] [Related]
40. Beta2-microglobulin-containing IgG complexes in sera and synovial fluids of rheumatoid arthritis and systemic lupus erythematosus patients.
Falus A; Merétey K; Glikmann G; Svehag SE; Fábián F; Böhm U; Bozsöky S
Scand J Immunol; 1981; 13(1):25-34. PubMed ID: 6165072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
